Bristol-Myers Squibb
BMY
#173
Rank
โ‚ฌ104.96 B
Marketcap
51,54ย โ‚ฌ
Share price
0.60%
Change (1 day)
-0.96%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): 2,62ย โ‚ฌ

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is 2,52ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -3,76ย โ‚ฌ a decrease over its 2023 EPS that were of 3,30ย โ‚ฌ.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)2,62ย โ‚ฌ-169.76%
2024-3,76ย โ‚ฌ-213.92%
20233,30ย โ‚ฌ30.2%
20222,53ย โ‚ฌ-6.04%
20212,69ย โ‚ฌ-179.29%
2020-3,40ย โ‚ฌ-281.37%
20191,87ย โ‚ฌ-27.21%
20182,57ย โ‚ฌ
20162,27ย โ‚ฌ175.26%
20150,82ย โ‚ฌ-19.83%
20141,03ย โ‚ฌ-22.44%
20131,33ย โ‚ฌ34.48%
20120,99ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
9,46ย โ‚ฌ 275.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,25ย โ‚ฌ 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1,16ย โ‚ฌ-54.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
2,03ย โ‚ฌ-19.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
19,56ย โ‚ฌ 675.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
12,18ย โ‚ฌ 382.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1,75ย โ‚ฌ-30.47%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
9,34ย โ‚ฌ 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,21ย โ‚ฌ 146.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4,55ย โ‚ฌ 80.13%๐Ÿ‡ฌ๐Ÿ‡ง UK